BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25752189)

  • 1. Combined medico-surgical strategy for invasive sino-orbito-cerebral breakthrough fungal infection with Hormographiella aspergillata in an acute leukaemia patient.
    Heiblig M; Bozzoli V; Saison J; Thomas X; De Croze D; Traverse-Glehen A; Cosmidis A; Chidiac C; Ferry T; Alanio A; Bienvenu AL; Dupont D; Ducastelle-Lepretre S; Michallet M; Ader F;
    Mycoses; 2015 May; 58(5):308-12. PubMed ID: 25752189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal skin and pulmonary infection caused by Hormographiella aspergillata in a leukaemic patient: case report and literature overview.
    Bojic M; Willinger B; Rath T; Tobudic S; Thalhammer F; Böhm A; Mitterbauer M; Schulenburg A; Wöhrer S; Kalhs P; Rabitsch W
    Mycoses; 2013 Nov; 56(6):687-9. PubMed ID: 23672484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Hormographiella aspergillata infection with involvement of the lung, brain, and small intestine following allogeneic hematopoietic stem cell transplantation: case report and literature review.
    Nanno S; Nakane T; Okamura H; Nishimoto M; Koh H; Nakamae H; Ohsawa M; Yarita K; Kamei K; Hino M
    Transpl Infect Dis; 2016 Aug; 18(4):611-6. PubMed ID: 27237466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakthrough Hormographiella aspergillata Infection in a Patient with Acute Myeloid Leukemia Receiving Posaconazole Prophylaxis: A Case Report and Review.
    Isabel Cristina RS; Diana A; Karen A
    Mycopathologia; 2020 Dec; 185(6):1069-1076. PubMed ID: 32880829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin.
    Suarez F; Olivier G; Garcia-Hermoso D; Randriamalala E; Ghez D; Bruneau J; Kauffmann-Lacroix C; Bougnoux ME; Lortholary O
    J Clin Microbiol; 2011 Jan; 49(1):461-5. PubMed ID: 21068290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough Invasive Sinusitis by Hormographiella aspergillata in a Neutropenic Patient Receiving Voriconazole Therapy: A Case Report and Review of Breakthrough H. aspergillata Infections.
    Florez-Riaño AF; Ramírez-Sánchez IC
    Mycopathologia; 2023 Aug; 188(4):401-407. PubMed ID: 37389746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormographiella aspergillata: an emerging mould in acute leukaemia patients?
    Conen A; Weisser M; Hohler D; Frei R; Stern M
    Clin Microbiol Infect; 2011 Feb; 17(2):273-7. PubMed ID: 20491830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated Hormographiella aspergillata Infection with Lung and Brain Involvement after Allogenic Hematopoietic Stem-Cell Transplantation in a 54-Year-Old Man.
    Chauhan A; Gruenberg J; Arbefeville S; Mettler T; Brent CH; Ferrieri P
    Lab Med; 2019 Oct; 50(4):426-431. PubMed ID: 31065690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
    Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
    Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough invasive mould infections in patients treated with caspofungin.
    Pang KA; Godet C; Fekkar A; Scholler J; Nivoix Y; Letscher-Bru V; Massias L; Kauffmann-Lacroix C; Elsendoorn A; Uzunov M; Datry A; Herbrecht R
    J Infect; 2012 Apr; 64(4):424-9. PubMed ID: 22227384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature.
    Schuermans C; van Bergen M; Coorevits L; Verhaegen J; Lagrou K; Surmont I; Jeurissen A
    Med Mycol; 2011 May; 49(4):414-8. PubMed ID: 21105848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.
    Lafaurie M; Lapalu J; Raffoux E; Breton B; Lacroix C; Socié G; Porcher R; Ribaud P; Touratier S; Molina JM
    Clin Microbiol Infect; 2010 Aug; 16(8):1191-6. PubMed ID: 19735276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular infection caused by Hormographiella aspergillata: A case report and review of literature.
    Jain N; Jinagal J; Kaur H; Ghosh A; Gupta S; Ram J; Rudramurthy SM
    J Mycol Med; 2019 Apr; 29(1):71-74. PubMed ID: 30630667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormographiella aspergillata: an emerging basidiomycete in the clinical setting? A case report and literature review.
    Moniot M; Lavergne RA; Morel T; Guieze R; Morio F; Poirier P; Nourrisson C
    BMC Infect Dis; 2020 Dec; 20(1):945. PubMed ID: 33308180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormographiella aspergillata pulmonary infections: Detection and identification of the fungus using pan-fungal PCR assays and DNA sequencing.
    Nevez G; Guillerm G; Talarmin JP; Quinio D; Iriart X; Lissillour PL; Rezig S; Fangous MS; Ranty M; Bodenes L; Aubron C; Couturier MA; Le Gal S
    J Mycol Med; 2024 Mar; 34(1):101463. PubMed ID: 38342037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review.
    Godet C; Cateau E; Rammaert B; Grosset M; Le Moal G; Béraud G; Martellosio JP; Iriart X; Cadranel J; Roblot F
    Mycopathologia; 2017 Aug; 182(7-8):709-713. PubMed ID: 28144821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
    Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
    Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia.
    Abuali MM; Posada R; Del Toro G; Roman E; Ramani R; Chaturvedi S; Chaturvedi V; LaBombardi VJ
    J Clin Microbiol; 2009 Dec; 47(12):4176-9. PubMed ID: 19846651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.
    Madureira A; Bergeron A; Lacroix C; Robin M; Rocha V; de Latour RP; Ferry C; Devergie A; Lapalu J; Gluckmana E; Socié G; Ghannoum M; Ribaud P
    Int J Antimicrob Agents; 2007 Dec; 30(6):551-4. PubMed ID: 18029149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.